Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
API Stability Enhancers
Solubilizers
Thickeners and Stabilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Betamethasone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier.
A Betamethasone Sodium Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betamethasone Sodium Phosphate, including repackagers and relabelers. The FDA regulates Betamethasone Sodium Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betamethasone Sodium Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betamethasone Sodium Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Betamethasone Sodium Phosphate supplier is an individual or a company that provides Betamethasone Sodium Phosphate active pharmaceutical ingredient (API) or Betamethasone Sodium Phosphate finished formulations upon request. The Betamethasone Sodium Phosphate suppliers may include Betamethasone Sodium Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Betamethasone Sodium Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Betamethasone Sodium Phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Betamethasone Sodium Phosphate active pharmaceutical ingredient (API) in detail. Different forms of Betamethasone Sodium Phosphate DMFs exist exist since differing nations have different regulations, such as Betamethasone Sodium Phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betamethasone Sodium Phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Betamethasone Sodium Phosphate USDMF includes data on Betamethasone Sodium Phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betamethasone Sodium Phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betamethasone Sodium Phosphate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Betamethasone Sodium Phosphate Drug Master File in Japan (Betamethasone Sodium Phosphate JDMF) empowers Betamethasone Sodium Phosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Betamethasone Sodium Phosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Betamethasone Sodium Phosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Betamethasone Sodium Phosphate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Betamethasone Sodium Phosphate Drug Master File in Korea (Betamethasone Sodium Phosphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Betamethasone Sodium Phosphate. The MFDS reviews the Betamethasone Sodium Phosphate KDMF as part of the drug registration process and uses the information provided in the Betamethasone Sodium Phosphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Betamethasone Sodium Phosphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Betamethasone Sodium Phosphate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Betamethasone Sodium Phosphate suppliers with KDMF on PharmaCompass.
A Betamethasone Sodium Phosphate CEP of the European Pharmacopoeia monograph is often referred to as a Betamethasone Sodium Phosphate Certificate of Suitability (COS). The purpose of a Betamethasone Sodium Phosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Betamethasone Sodium Phosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Betamethasone Sodium Phosphate to their clients by showing that a Betamethasone Sodium Phosphate CEP has been issued for it. The manufacturer submits a Betamethasone Sodium Phosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Betamethasone Sodium Phosphate CEP holder for the record. Additionally, the data presented in the Betamethasone Sodium Phosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Betamethasone Sodium Phosphate DMF.
A Betamethasone Sodium Phosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Betamethasone Sodium Phosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Betamethasone Sodium Phosphate suppliers with CEP (COS) on PharmaCompass.
A Betamethasone Sodium Phosphate written confirmation (Betamethasone Sodium Phosphate WC) is an official document issued by a regulatory agency to a Betamethasone Sodium Phosphate manufacturer, verifying that the manufacturing facility of a Betamethasone Sodium Phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Betamethasone Sodium Phosphate APIs or Betamethasone Sodium Phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Betamethasone Sodium Phosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Betamethasone Sodium Phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Betamethasone Sodium Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Betamethasone Sodium Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Betamethasone Sodium Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Betamethasone Sodium Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Betamethasone Sodium Phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Betamethasone Sodium Phosphate suppliers with NDC on PharmaCompass.
Betamethasone Sodium Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betamethasone Sodium Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Betamethasone Sodium Phosphate GMP manufacturer or Betamethasone Sodium Phosphate GMP API supplier for your needs.
A Betamethasone Sodium Phosphate CoA (Certificate of Analysis) is a formal document that attests to Betamethasone Sodium Phosphate's compliance with Betamethasone Sodium Phosphate specifications and serves as a tool for batch-level quality control.
Betamethasone Sodium Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Betamethasone Sodium Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betamethasone Sodium Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Betamethasone Sodium Phosphate EP), Betamethasone Sodium Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betamethasone Sodium Phosphate USP).
